← back to search

Shane M. Wilkinson

The University of Sydney · AU
Area of research
Physical and Theoretical Chemistry · Pharmacology
Research interest
Research interests include Various Chemistry Research Topics, Cannabis and Cannabinoid Research, Neurotransmitter Receptor Influence on Behavior, and Forensic Toxicology and Drug Analysis.
h-index
18
citations
1,629
works
41
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation
Scientific Reports 2018cited by 78position: middledoi
Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X<sub>7</sub> Receptor Antagonist
ACS Chemical Neuroscience 2017cited by 53position: firstdoi
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
ACS Chemical Neuroscience 2015cited by 240position: middledoi
Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135
ACS Chemical Neuroscience 2015cited by 196position: middledoi
Synthesis and Characterization of Metal Complexes with Schiff Base Ligands
Journal of Chemical Education 2015cited by 60position: firstdoi
The First CNS-Active Carborane: A Novel P2X<sub>7</sub> Receptor Antagonist with Antidepressant Activity
ACS Chemical Neuroscience 2014cited by 137position: firstdoi
[18F]DPA-714: Direct Comparison with [11C]PK11195 in a Model of Cerebral Ischemia in Rats
PLoS ONE 2013cited by 88position: middledoi
The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse
ACS Chemical Neuroscience 2013cited by 86position: middledoi
Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion
PLoS ONE 2012cited by 62position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael Kassiou · The University of Sydney7 papers (2013–2018)Samuel D. Banister · The University of Sydney4 papers (2013–2015)Mark Connor · Macquarie University3 papers (2013–2015)Mitchell Longworth · The University of Sydney3 papers (2013–2015)Michelle Glass · University of Otago3 papers (2013–2015)David E. Hibbs · The University of Sydney3 papers (2013–2017)Bieneke Janssen · Radboud University Medical Center2 papers (2017–2018)Albert D. Windhorst · Breast Cancer Research Foundation2 papers (2017–2018)Daniëlle J. Vugts · Netherlands Center for Occupational Diseases2 papers (2017–2018)Mansoor Chishty · Pharmidex (United Kingdom)2 papers (2017–2018)Corinne Beinat · Stanford Medicine2 papers (2015–2015)— · 2 papers (2015–2015)Melissa L. Barron · University of Sydney2 papers (2014–2017)Jennifer Ong · The University of Sydney1 papers (2017–2017)James O’Brien-Brown · University of Sydney1 papers (2017–2017)— · 1 papers (2018–2018)Paul D. Callaghan · Australian Nuclear Science and Technology Organisation1 papers (2012–2012)Christopher Cawthorne · KU Leuven1 papers (2013–2013)Eryn L. Werry · The University of Sydney1 papers (2017–2017)— · 1 papers (2018–2018)